The role:

Head of Business Development and Sales



Contracted hours:

Part-time to full-time

Contract type:

Fixed-term contract, with permanent role potential

Start date:


Job creation reason:

New role as part of an expanding company


Share options and generous cash-based commission

Opportunity to join an award-winning startup, to help grow its client base and help improve outcomes for millions of people with cancer around the world.

RareCan is a UK health tech start up developing novel patient and data pipelines, underpinned by proprietary technology, to accelerate the pace at which the global pharmaceutical industry brings precision oncology medicines to market and ultimately improve treatments for cancer patients.

We are looking for someone smart, sharp and ambitious with previous experience of business development and sales in a related field (pharmaceutical industry, biotech, lifesciences, health) who is up for getting stuck in at the sharp end of a start up. As the Head of Business Development and Sales you will build on the significant traction we already have across both the pharmaceutical industry and with many of the world’s leading contract research organisations, to build our client base and rapidly grow our revenues.

Role description

You will head up our business development and sales activity, taking a lead across our lead generation and client account development, identifying and developing new business opportunities, right through to closing contracts.

Responsibilities and activities will include:

  • Prospect and identify potential clients who have the capacity and need for our products/services, with a focus on high-value opportunities.
  • Build and maintain strong relationships with key decision-makers within target organisations, including C-level executives and senior management.
  • Understand clients’ business objectives, challenges, and requirements to effectively position our offerings as the optimal solution.
  • Build and take ownership of a sales pipeline, ensuring opportunities are nurtured through to close.
  • Work with your the founders to support complex contract negotiations, including pricing and terms, while maintaining a focus on long-term client relationships.
  • Collaborate closely with internal teams, including account management, product development, marketing, and customer support, to ensure seamless execution and customer satisfaction.
  • Conduct thorough market research and competitor analysis to gain a competitive advantage and stay up to date with industry trends.
  • Accurately maintain data, self-analyse progress and produce reports based on KPIs from RareCans CRM, Hubspot.
  • Over time, this role could develop into a full time position with international travel requirements.

Person specification

We are looking for someone who has experience and a proven track record in sales, and who is in a position to come and work for a startup on a share option and commission-based remuneration package initially. We know this isn’t possible for everyone, so want to be really clear on this point. This role will have a really attractive cash-based commission structure, but the base salary will be paid in share options not cash. We have significant traction in our target client base so you won’t be starting from scratch, but you will need to be willing to get paid based on the business you secure.

You will:

  • Have a relevant life science degree or a decent amount of relevant experience
  • Have previous experience and a proven track record in sales in a related industry
  • Have the confidence and communications skills to ‘get out there’ and build relationships with contacts across our target client base at all levels of seniority
  • Be able to work remotely under your own steam, motivating yourself, whilst collaborating with your colleagues where appropriate
  • Finally, and crucial to any fast growing company, be a solution-minded team player, willing to share what’s working and help the team succeed together

Contact us

If you are interested, please get in touch with our Chief Executive, Piers Kotting via LinkedIn.